In the last trading session, 4.94 million Esperion Therapeutics Inc (NASDAQ:ESPR) shares changed hands as the company’s beta touched 0.64. With the company’s per share price at $0.80 changed hands at $0.02 or 3.17% during last session, the market valuation stood at $158.92M. ESPR’s last price was a discount, traded about -392.5% off its 52-week high of $3.94. The share price had its 52-week low at $0.69, which suggests the last value was 13.75% up since then.
Analysts gave the Esperion Therapeutics Inc (ESPR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.88. If we narrow down to specifics, the data shows that 0 out of 8 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended ESPR as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight.
Esperion Therapeutics Inc (NASDAQ:ESPR) trade information
Instantly ESPR was in green as seen at the end of in last trading. With action 0.45%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -63.55%, with the 5-day performance at 0.45% in the green. However, in the 30-day time frame, Esperion Therapeutics Inc (NASDAQ:ESPR) is -16.82% down.
The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 90.0% from its current market value. According to analyst projections, ESPR’s forecast low is 8 with 8 as the target high. To hit the forecast high, the stock’s price needs a -900.0% plunge from its current level, while the stock would need to soar -900.0% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 40.11%. The 2025 estimates are for Esperion Therapeutics Inc earnings to increase by 40.18%.
ESPR Dividends
Esperion Therapeutics Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.4068% or 13.98 million shares worth $31.04 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were WASATCH FUNDS TRUST-Wasatch Ultra Growth Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 6.68 shares estimated at $5.35 million under it, the former controlled 3.37% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 3.12% of the shares, roughly 6.18 shares worth around $4.95 million.
